000 01572 a2200469 4500
005 20250514063027.0
264 0 _c20030926
008 200309s 0 0 eng d
022 _a1043-0342
024 7 _a10.1089/104303403321208970
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMuhs, Andreas
245 0 0 _aPreclinical evaluation of inducible nitric oxide synthase lipoplex gene therapy for inhibition of stent-induced vascular neointimal lesion formation.
_h[electronic resource]
260 _bHuman gene therapy
_cMar 2003
300 _a375-83 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aArterial Occlusive Diseases
_xetiology
650 0 4 _aCell Death
650 0 4 _aCoronary Stenosis
_xetiology
650 0 4 _aGenetic Therapy
650 0 4 _aGenetic Vectors
650 0 4 _aImmunohistochemistry
650 0 4 _aLiposomes
650 0 4 _aNitric Oxide Synthase
_xanalysis
650 0 4 _aNitric Oxide Synthase Type II
650 0 4 _aStents
650 0 4 _aSwine, Miniature
650 0 4 _aTransfection
650 0 4 _aTunica Intima
_xpathology
700 1 _aHeublein, Bernd
700 1 _aSchletter, Jens
700 1 _aHerrmann, Andreas
700 1 _aRüdiger, Manfred
700 1 _aSturm, Matthias
700 1 _aGrust, Andreas
700 1 _aMalms, Jochen
700 1 _aSchrader, Jürgen
700 1 _avon der Leyen, Heiko E
773 0 _tHuman gene therapy
_gvol. 14
_gno. 4
_gp. 375-83
856 4 0 _uhttps://doi.org/10.1089/104303403321208970
_zAvailable from publisher's website
999 _c12453218
_d12453218